Document Detail


Adrenal vein sampling may not be a gold-standard diagnostic test in primary aldosteronism: final diagnosis depends upon which interpretation rule is used. Variable interpretation of adrenal vein sampling.
MedLine Citation:
PMID:  18696249     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Adrenal vein sampling (AVS) is considered the gold-standard test to demonstrate unilateral aldosterone excess in primary aldosteronism, yet no single approach to interpretation of AVS has been externally validated. HYPOTHESIS: There may be significant inter-observer variability in the final diagnosis of unilateral vs. bilateral aldosterone excess depending on which AVS interpretation rule is used. METHODS: Retrospective chart review of 63 subjects with primary aldosteronism undergoing AVS and 40 subsequent adrenalectomies for presumed unilateral aldosteronism. The data from the AVS were retrospectively re-analyzed according to a variety of interpretation criteria published in the literature. Using 40 subjects undergoing surgery, pathology and clinical outcomes defined the final diagnosis of aldosteronism subtype, and these subjects' AVS results were used to estimate the true sensitivity and specificity of the various approaches to AVS interpretation. RESULTS: Diagnostic discrepancies exist between the different AVS interpretation rules. Successful adrenal vein catheterization was confirmed in between 13% and 77% of AVS attempts. Sensitivity of AVS ranged from 47% to 100% and specificity 55-100%. Only 17% of all cases would be categorized uniformly by all interpretation criteria. Use of biochemical catheter placement criteria and ACTH infusion improved the proportions of AVS results defined as successful and showing lateralization. CONCLUSIONS: We found substantial variabilty in final diagnosis by using different systems of interpreting AVS results as suggested in the literature This suggests AVS may not always be considered a gold-standard diagnostic test.
Authors:
Gregory A Kline; Adrian Harvey; Charlotte Jones; Michael H Hill; Benny So; Nairne Scott-Douglas; Janice L Pasieka
Related Documents :
19893829 - General practice and the nhhrc report.
10483959 - The relative influence of secondary versus primary prevention using the national choles...
15533539 - Global initiative for chronic obstructive lung disease for chronic obstructive pulmonar...
2336569 - Primary health care in a multi-level perspective: towards a research agenda.
8554209 - Health care for persons with non-insulin-dependent diabetes mellitus. the german experi...
11906989 - Walk-in clinics: patient expectations and family physician availability.
9159709 - The dynamics of market-level change.
8924709 - Special challenges of maintaining wild animals in captivity in north america.
18603859 - Risk factors, associated health problems, reasons for admission and knowledge profile o...
Publication Detail:
Type:  Journal Article     Date:  2008-08-12
Journal Detail:
Title:  International urology and nephrology     Volume:  40     ISSN:  0301-1623     ISO Abbreviation:  Int Urol Nephrol     Publication Date:  2008  
Date Detail:
Created Date:  2008-11-07     Completed Date:  2009-03-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0262521     Medline TA:  Int Urol Nephrol     Country:  Hungary    
Other Details:
Languages:  eng     Pagination:  1035-43     Citation Subset:  IM    
Affiliation:
Division of Endocrinology, University of Calgary, Calgary, AB, Canada, T2N 4J8. gakline@ucalgary.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Glands / blood supply*,  surgery
Adrenalectomy
Diagnosis, Differential
Humans
Hyperaldosteronism / diagnosis*,  surgery
Observer Variation
Retrospective Studies
Sensitivity and Specificity

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modification of gibberellin signalling (metabolism & signal transduction) in sugar beet: analysi...
Next Document:  Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?